环状RNA核受体相互作用蛋白1对肿瘤发生发展的调控机制研究进展

doi:10.16352/j.issn.1001-6325.2023.05.0827

基础医学与临床 ›› 2023, Vol. 43 ›› Issue (5): 827-832.doi: 10.16352/j.issn.1001-6325.2023.05.0827

环状RNA核受体相互作用蛋白1对肿瘤发生发展的调控机制研究进展

高欣, 于永波, 王海存, 姜兴明^*, 王志东

哈尔滨医科大学附属第二医院普通外科,黑龙江哈尔滨 150086

收稿日期:2022-03-22 修回日期:2022-06-29 出版日期:2023-05-05 发布日期:2023-04-26
通讯作者: ^*xmjiang@hrbmu.edu.cn
基金资助:
黑龙江省博士后科学基金(LBH-Q21023);黑龙江省自然科学基金(LH2020H058);湖北陈孝平科技发展基金(CXPJJH12000002-2020015)

Research progress on regulatory mechanisms of circular RNA nuclear receptor interacting protein 1 in tumor occurrence and development

GAO Xin, YU Yongbo, WANG Haicun, JIANG Xingming^*, WANG Zhidong

Department of General Surgery, the 2nd Affiliated Hospital of Harbin Medical University, Harbin 150086, China

Received:2022-03-22 Revised:2022-06-29 Online:2023-05-05 Published:2023-04-26
Contact: ^*xmjiang@hrbmu.edu.cn

摘要/Abstract

摘要： 环状RNA(circRNA)是一类广泛表达于真核细胞的单链共价闭合性非编码RNA分子。近来研究发现circRNA参与调控细胞增殖、分化、凋亡等生物学过程,是肿瘤发生发展的关键调节因子。环状RNA核受体相互作用蛋白1(circ_NRIP1)作为一种环状RNA,在诸多人类肿瘤中呈现异常表达并能够调控肿瘤增殖和侵袭迁移等恶性生物学行为。阐明circ_NRIP1在肿瘤发生发展中的调控机制,能够为肿瘤诊断和治疗指明新的方向。

关键词: 环状RNA, 环状RNA核受体相互作用蛋白1(circ_NRIP1), 肿瘤发生发展, 调控机制

Abstract: Circular RNA (circRNA) is a class of single-stranded covalently closed non-coding RNA molecules widely expressed in eukaryotic cells. Recent studies have found that circRNA has been involved in modulating biological processes such as cell proliferation, differentiation, and apoptosis so it is the key regulator of tumor occurrence and development. Circular RNA nuclear receptor interacting protein 1(circ_NRIP1), as a circular RNA, is abnormally expressed in various human cancers and potentially regulates malignant biological behaviors such as tumor proliferation, invasion and migration. Elucidating the regulatory mechanisms of circ_NRIP1 in tumor occurrence and development may provide a new strategy for tumor diagnosis and treatment.

Key words: circular RNA, circular RNA nuclear receptor interacting protein 1(circ_NRIP1), tumor occurrence and development, regulatory mechanism

中图分类号:

R730

高欣, 于永波, 王海存, 姜兴明, 王志东. 环状RNA核受体相互作用蛋白1对肿瘤发生发展的调控机制研究进展[J]. 基础医学与临床, 2023, 43(5): 827-832.

GAO Xin, YU Yongbo, WANG Haicun, JIANG Xingming, WANG Zhidong. Research progress on regulatory mechanisms of circular RNA nuclear receptor interacting protein 1 in tumor occurrence and development[J]. Basic & Clinical Medicine, 2023, 43(5): 827-832.

参考文献

[1]Liu CX, Guo SK, Nan F, et al. RNA circles with minimized immunogenicity as potent PKR inhibitors[J]. Mol Cell, 2022, 82: 420-434.
[2]Rossi F, Beltran M, Damizia M, et al. Circular RNA ZNF609/CKAP5 mRNA interaction regulates microtubule dynamics and tumorigenicity[J]. Mol Cell, 2022, 82: 75-89.
[3]刘青, 张蕾, 张利元, 等. Circ0038467靶向miR-182调控肺炎链球菌(Sp)诱导的人肺泡上皮细胞系HPAEpiC损伤[J]. 基础医学与临床, 2021, 41: 1277-1284.
[4]Li YP, Wang F, Teng P, et al. Accurate identification of circRNA landscape and complexity reveals their pivotal roles in human oligodendroglia differentiation[J]. Genome Biol, 2022, 23: 48. doi: 10.1186/s13059-022-02621-1.
[5]关沧海, 刘浪, 史武江, 等. LncRNA SNHG20通过miR-520f-3p调控胆管癌细胞增殖和侵袭[J]. 中国癌症防治杂志, 2021, 13: 389-394.
[6]Li M, Cai JN, Han XR, et al. Downregulation of circNRIP1 suppresses the paclitaxel resistance of ovarian cancer via regulating the miR-211-5p/HOXC8 axis[J]. Cancer Manag Res, 2020, 12: 9159-9171.
[7]Li XH, Ma NY, Zhang Y, et al. Circular RNA circNRIP1 promotes migration and invasion in cervical cancer by sponging miR-629-3p and regulating the PTP4A1/ERK1/2 pathway[J]. Cell Death Dis, 2020, 11: 399. doi: 10.1038/s41419-020-2607-9.
[8]Pan B, Qin J, Liu XX, et al. Identification of serum exosomal has-circ-0004771 as a novel diagnostic biomarker of colorectal cancer[J]. Front Genet, 2019, 10: 1096.doi: 10.3389/sgene.2019.01096.
[9]Xu YH, Kong S, Qin XY. et al. Comprehensive assess-ment of plasma circ_0004771 as a novel diagnostic and dynamic monitoring biomarker in gastric cancer[J]. Onco Targets Ther, 2020, 13: 10063-10074.
[10]陈婧, 张荣, 王浩斌, 等. 血清circNRIP1表达在胃癌诊疗中的临床意义[J]. 胃肠病学, 2021, 26: 39-42.
[11]Xu GS, Li ML, Wu J, et al. Circular RNA circNRIP1 sponges microRNA-138-5p to maintain hypoxia-induced resistance to 5-Fluorouracil through HIF-1α-dependent glucose metabolism in gastric carcinoma[J]. Cancer Manag Res, 2020, 12: 2789-2802.
[12]Liu YH, Jiang YY, Xu LD, et al. Circ-NRIP1 promotes glycolysis and tumor progression by regulating miR-186-5p/MYH9 axis in gastric cancer[J]. Cancer Manag Res, 2020, 12: 5945-5956.
[13]Huang EM, Fu JH, Yu QY, et al. CircRNA has_circ_0004771 promotes esophageal squamous cell cancer progression via miR-339-5p/CDC25A axis[J]. Epigenomics, 2020, 12: 587-603.
[14]王灵霞, 严玉兰, 袁海涛, 等. CircRNA_23113抑制肺腺癌细胞的增殖和迁移[J]. 基础医学与临床, 2022, 42: 82-88.
[15]Ambrosi S, Visser A, Antunes-Ferreira M, et al. The analysis of platelet-derived circRNA repertoire as potential diagnostic biomarker for non-small cell lung cancer[J]. Cancers, 2021, 13: 4644. doi: 10.3390/cancers13184644.
[16]杨露, 丁剑桥, 陈金鑫, 等. 环状RNA circ_0004771对肺腺癌细胞A549的增殖、迁移与侵袭的影响[J]. 中华解剖与临床杂志, 2022, 27: 42-47.
[17]Lin JW, Qin H, Han Y, et al. CircNRIP1 modulates the miR-515-5p/IL-25 Axis to control 5-Fu and cisplatin resistance in nasopharyngeal carcinoma[J]. Drug Des Devel Ther, 2021, 15: 323-330.
[18]Li C, Zhu LJ, Fu LJ, et al. CircRNA NRIP1 promotes papillary thyroid carcinoma progression by sponging miR-195-5p and modulating the P38 MAPK and JAK/STAT pathways[J]. Diagn Pathol, 2021, 16: 93. doi: 10.1186/s13000-021-01153-9.
[19]Meng YB, Hao DJ, Huang YF, et al. Circular RNA circNRIP1 plays oncogenic roles in the progression of osteosarcoma[J]. Mamm Genome, 2021, 32: 448-456.
[20]Shi ZW, Wang KF, Xing YF, et al. CircNRIP1 encapsulated by bone marrow mesenchymal stem cell-derived extracellular vesicles aggravates osteosarcoma by modulating the miR-532-3p/AKT3/PI3K/AKT axis[J]. Front Oncol, 2021, 11: 658139. doi: 10.3389/fonc.2021.658139.
[21]Xie R, Tang J, Zhu XM, et al. Silencing of has_circ_0004771 inhibits proliferation and induces apoptosis in breast cancer through activation of miR-653 by targeting ZEB2 signaling pathway[J]. Biosci Rep, 2019, 39: BSR20181919.
[22]Ye X, Tam WL, Shibue T, et al. Distinct EMT programs control normal mammary stem cells and tumour-initiating cells[J]. Nature, 2015, 525: 256-260.
[23]Zhang X, Wang S, Wang HX, et al. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway[J]. Mol Cancer, 2019, 18: 20. doi: 10.1186/s12943-018-0935-5.
[24]Ding XB, Zheng JJ, Cao MX. Circ_0004771 accelerates cell carcinogenic phenotypes via suppressing miR-1253-mediated DDAH1 inhibition in breast cancer[J]. Cancer Manag Res, 2021, 13: 1-11.
[25]Huang TT, Brill E, Nair JR, et al. Targeting the PI3K/mTOR pathway augments CHK1 inhibitor-induced replication stress and antitumor activity in high-grade serous ovarian cancer[J]. Cancer Res, 2020, 80: 5380-5392.
[26]Zhou S, Guo Z, Zhou C, et al. Circ_NRIP1 is oncogenic in malignant development of esophageal squamous cell carcinoma (ESCC) via miR-595/SEMA4D axis and PI3K/AKT pathway[J]. Cancer Cell Int, 2021, 21: 250.doi: 10.1186/s12935-021-01907-x.
[27]Zhang YG, Lu R, Wu S, et al. Vitamin D receptor protects against dysbiosis and tumorigenesis via the JAK/STAT pathway in intestine[J]. Cell Mol Gastroenterol Hepatol, 2020, 10: 729-746.
[28]Liu FF, Li RJ, Zhang R, et al. Knockdown of circNRIP1 sensitizes colorectal cancer to 5-FU via sponging miR-532-3p[J]. Oncol Rep, 2021, 46: 218.doi: 10.3892/07.2021.8169.
[29]Taulli R, Loretelli C, Pandolfi PP. From pseudo-ceRNAs to circ-ceRNAs: a tale of cross-talk and competition[J]. Nat Struct Mol Biol, 2013, 20: 541-543.
[30]Liang L, Li L. Down-regulation of circNRIP1 promotes the apoptosis and inhibits the migration and invasion of gastric cancer cells by miR-182/ROCK1 axis[J]. Onco Targets Ther, 2020, 13: 6279-6288.
[31]Lei M, Zheng G, Ning Q, et al. Translation and functional roles of circular RNAs in human cancer[J]. Mol Cancer, 2020, 19: 30. doi: 10.1186/s12943-020-1135-7.
[32]Legnini I, Di Timoteo G, Rossi F, et al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis[J]. Mol Cell, 2017, 66: 22-37.

环状RNA核受体相互作用蛋白1对肿瘤发生发展的调控机制研究进展

Research progress on regulatory mechanisms of circular RNA nuclear receptor interacting protein 1 in tumor occurrence and development

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 7

编辑推荐

Metrics

本文评价

[1]	李江丽, 孙静, 唐一君, 郭君兰, 陈博, 郭胜男. Circ-DDX5靶向miR-3940抑制人乳腺癌细胞系的增殖和侵袭[J]. 基础医学与临床, 2024, 44(1): 1-7.
[2]	依马木买买提江·阿布拉, 帕哈尔丁·白克热, 易超, 佟庆. 血浆hsa_circ_005230在原发性肝细胞癌诊断和预后评估中的临床价值[J]. 基础医学与临床, 2023, 43(9): 1417-1422.
[3]	郑彬彬, 林淑莹, 李德隆, 陈杰, 黄子成. 环状RNA ATP2B1靶向miR-452-5p降低胃癌细胞系的增殖和侵袭[J]. 基础医学与临床, 2023, 43(6): 882-888.
[4]	何啸, 胡为杰, 吕文昌, 任玉萍, 吴敏, 吴毅平, 张奇. 环状RNA在乳腺癌中作用的研究进展[J]. 基础医学与临床, 2022, 42(3): 507-511.
[5]	刘浪, 王海存, 高欣, 刘广麟, 赵俞乔, 姜兴明. CircRNA锌指RNA结合蛋白在恶性肿瘤中作用研究进展[J]. 基础医学与临床, 2022, 42(10): 1585-1590.
[6]	冯天瑞, 严维刚. 环状RNAs在前列腺癌中的研究进展[J]. 基础医学与临床, 2022, 42(1): 179-183.
[7]	王椋刘国强赵凯杨丹丹徐敏邢健丁慧芳. miR-342-3p有助于人脂肪来源间充质干细胞成脂分化过程[J]. 基础医学与临床, 2018, 38(11): 1532-1536.